I. Julier

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)

Ho Yee Cheung, James D. Clark, May Thin Khine, 2022, Cardiovascular Diabetology.

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

S. Hadjadj, M. Marre, R. Roussel, 2020, Diabetes & Metabolism.

C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome.

T. Mavrakanas, A. Soualah, F. Aloui, 2009, Presse medicale.

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19 the CORONADO investigators

S. Hadjadj, R. Roussel, P. Gourdy, 2021 .